Mirum Pharmaceuticals, Inc. Tech Stack

Biopharmaceutical company developing rare-disease treatments with three FDA-approved drugs

Pharmaceutical Manufacturing Foster City, CA 201–500 employees Founded 2018 Public Company

Mirum is a public biopharmaceutical company operating across clinical development, regulatory affairs, and commercial execution for rare liver and metabolic diseases. The tech stack is compliance-heavy (Veeva QMS, CDISC, SAS, Electronic Data Capture) and sales-infrastructure-focused (Salesforce, Adaptive Planning, Power BI), reflecting a tightly regulated environment where data integrity and audit readiness drive tooling choices. Active hiring across medical affairs, clinical, and finance—with director-level roles accelerating—signals scaling of evidence generation and regulatory operations alongside commercial growth.

Tech Stack 27 technologies

Core StackSalesforce SAS Azure AD Intune Okta Zoom Power BI Tableau Electronic Data Capture Komodo Adaptive Planning Veeva Outlook CDISC Windows Microsoft 365 Adobe Box OneDrive SharePoint Microsoft Office Teams Excel Veeva QMS PowerPoint VBA R

What Mirum Pharmaceuticals, Inc. Is Building

◆Challenges

Vendor management
Monitoring compliance data for anomalies
Inefficient commercial organization
Risk mitigation
Ensuring global regulatory compliance
Managing risk-based auditing program
Program governance
Portfolio oversight
Regulatory inspection readiness
Improving diagnosis rates

▲Active Projects

Congress and conference strategy
Hipaa and gdpr privacy initiatives
Audit management program
Regional advisory boards
Investigator-initiated research support
Global brand strategy for brelovitug
Advisory board planning
Clinical development programs for rare diseases
Regional symposia
Comprehensive compliance program development

Hiring Activity

Accelerating50 roles · 30 in 30d

Department

Healthcare

Finance

Ops

Legal

Marketing

Research

Sales

Clinical

Seniority

Director

Senior

Intern

Manager

Junior

Mid

Notable leadership hires: Global Medical Affairs Lead, Brand Lead, IT Integration Lead, CRM Lead, FP&A Director

Company intelligence

Find more companies like Mirum Pharmaceuticals, Inc. by tech stack, pain points and active projects

Get started free

About Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals develops and commercializes medications for rare diseases. The company portfolio includes three FDA-approved drugs: LIVMARLI (an IBAT inhibitor for cholestatic pruritus in Alagille syndrome and PFIC), CHOLBAM (cholic acid for bile acid synthesis disorders and peroxisomal disorders), and CTEXLI (chenodiol for cerebrotendinous xanthomatosis). The pipeline includes late-stage investigational therapies for primary sclerosing cholangitis and other rare cholestatic conditions. Based in Foster City, California, Mirum operates across the United States, Germany, and Switzerland with 201–500 employees. The organization balances clinical development, regulatory strategy, and commercial execution for a patient population spanning pediatric and adult rare-disease indications.

HeadquartersFoster City, CA

Company Size201–500 employees

Founded2018

Hiring MarketsUnited States, Germany, Switzerland

Frequently Asked Questions

What tech stack does Mirum Pharmaceuticals use?

Mirum's primary tools include Veeva (QMS and CRM), Salesforce, SAS, Electronic Data Capture, CDISC standards, Adaptive Planning, Power BI, Tableau, and Microsoft cloud services (Azure AD, Microsoft 365, Teams, OneDrive, SharePoint). The stack emphasizes regulatory compliance, data standardization, and commercial analytics.

What FDA-approved drugs does Mirum Pharmaceuticals sell?

Mirum has three approved medications: LIVMARLI (maralixibat) for cholestatic pruritus in Alagille syndrome and PFIC; CHOLBAM (cholic acid) for bile acid synthesis disorders and peroxisomal disorders; and CTEXLI (chenodiol) for cerebrotendinous xanthomatosis in adults.